Table 1:

Demographic and Clinical Characteristics of Participants at Baseline

Characteristic	(n = 35)
Age years, median (IQR)	43 (35–47)
Race or Ethnic Group
Black or African American	5 (14%)
White	17 (49%)
Other	3 (9%)
Hispanic or Latina	10 (28%)
DBS TFV-DP level fmol/punch, median (IQR)	1007 (726–1581)
CVF TFV level ng/mL, median (IQR) (n=34)	854 (125–2350)
Sexually transmitted infections (n=34)
Chlamydia	0 (0%)
Gonorrhea	0 (0%)
Vaginitis
Gardnerella (n=27)	11 (41%)
Candida (n=27)	2 (7%)
Trichomonas (n=27)	0 (0%)
Herpes Simplex Virus 1/2	4 (11%)
Cytomegalovirus	2 (6%)
HPV 16 or 18 (n=28)	6 (21%)
Vaginal Microbiota community group (n=34)
I	8 (24%)
II	1 (3%)
III	11 (32%)
IV	12 (35%)
V	2 (6%)
Cytokine detected
MIP 1alpha	7 (20%)
MIP 1 beta	7 (20%)
IP-10	8 (22.9%)
IL-8 (>20)	21 (60%)